Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer

The objective of the present study was to investigate the effect of tamoxifen (Tam) loaded solid lipid nanoparticles (SLNs) on MCF7 Tam-resistant breast cancer cells (MCF7-TamR). Tam-SLNs were produced by the hot homogenization method. The characterization studies of Tam-SLNs demonstrated good physi...

Full description

Saved in:
Bibliographic Details
Published in:European journal of pharmaceutical sciences 2018-07, Vol.120, p.73-88
Main Authors: Guney Eskiler, Gamze, Cecener, Gulsah, Dikmen, Gokhan, Egeli, Unal, Tunca, Berrin
Format: Article
Language:English
Subjects:
Apoptosis
Breast cancer
Drug resistance
Solid lipid nanoparticles
Tamoxifen
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c356t-c305c20f703b1950c95e2eff602ca64c3bc827c006cda8a7a414cb111870c3f73
cites cdi_FETCH-LOGICAL-c356t-c305c20f703b1950c95e2eff602ca64c3bc827c006cda8a7a414cb111870c3f73
container_end_page 88
container_issue
container_start_page 73
container_title European journal of pharmaceutical sciences
container_volume 120
creator Guney Eskiler, Gamze
Cecener, Gulsah
Dikmen, Gokhan
Egeli, Unal
Tunca, Berrin
description The objective of the present study was to investigate the effect of tamoxifen (Tam) loaded solid lipid nanoparticles (SLNs) on MCF7 Tam-resistant breast cancer cells (MCF7-TamR). Tam-SLNs were produced by the hot homogenization method. The characterization studies of Tam-SLNs demonstrated good physical stability with small particle size. The in vitro cytotoxicity results showed that Tam-SLNs enhanced the efficacy of Tam and reversed the acquired Tam resistance by inducing apoptosis, altering the expression levels of specific miRNA and the related apoptosis-associated target-genes in both MCF7 and MCF7-TamR cells without damaging the MCF10A control cells (p 
doi_str_mv 10.1016/j.ejps.2018.04.040
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2034287527</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0928098718302057</els_id><sourcerecordid>2034287527</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-c305c20f703b1950c95e2eff602ca64c3bc827c006cda8a7a414cb111870c3f73</originalsourceid><addsrcrecordid>eNp9kElLxEAQhRtRnHH0D3iQHL0kVneWTsSLDG4wILicm06lAh2y2Z0R_fd2mNGjULyi4NWj6mPsnEPEgWdXTUTN6CIBPI8g8QUHbMlzWYQgBRyyJRQiD6HI5YKdONcAQJZLOGYLUUheiASWbPM6tKYKWjN67XU_jNpOBlty18ELfZJ1ug2GOph0N3yZmvrAkjNu0j1SYPqgtKTdFOA821N2VOvW0dm-r9j7_d3b-jHcPD88rW83IcZpNnmFFAXUEuKSFylgkZKgus5AoM4SjEvMhUR_LVY611InPMGSc_8aYFzLeMUud7mjHT625CbVGYfUtrqnYeuUgDgRuUzFbBU7K9rBOUu1Gq3ptP1WHNRMUTVqpqhmigoSX-CXLvb527Kj6m_lF5s33OwM5L_8NGSVQ0MeQWUs4aSqwfyX_wNploNl</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2034287527</pqid></control><display><type>article</type><title>Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer</title><source>Elsevier</source><creator>Guney Eskiler, Gamze ; Cecener, Gulsah ; Dikmen, Gokhan ; Egeli, Unal ; Tunca, Berrin</creator><creatorcontrib>Guney Eskiler, Gamze ; Cecener, Gulsah ; Dikmen, Gokhan ; Egeli, Unal ; Tunca, Berrin</creatorcontrib><description>The objective of the present study was to investigate the effect of tamoxifen (Tam) loaded solid lipid nanoparticles (SLNs) on MCF7 Tam-resistant breast cancer cells (MCF7-TamR). Tam-SLNs were produced by the hot homogenization method. The characterization studies of Tam-SLNs demonstrated good physical stability with small particle size. The in vitro cytotoxicity results showed that Tam-SLNs enhanced the efficacy of Tam and reversed the acquired Tam resistance by inducing apoptosis, altering the expression levels of specific miRNA and the related apoptosis-associated target-genes in both MCF7 and MCF7-TamR cells without damaging the MCF10A control cells (p &lt; 0.05). In conclusion, we demonstrated a molecular mechanism of the induction of apoptosis by Tam-SLNs in MCF7 and MCF7-TamR cells, and thus, we demonstrated that Tam-SLNs were more effective than Tam. The present study suggests that the use SLNs may be a potential therapeutic strategy to overcome Tam-resistance in breast cancer for clinical use. Tam-SLNs could potentially overcome Tam-resistance by inducing apoptosis in breast cancer. [Display omitted]</description><identifier>ISSN: 0928-0987</identifier><identifier>EISSN: 1879-0720</identifier><identifier>DOI: 10.1016/j.ejps.2018.04.040</identifier><identifier>PMID: 29719240</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Apoptosis ; Breast cancer ; Drug resistance ; Solid lipid nanoparticles ; Tamoxifen</subject><ispartof>European journal of pharmaceutical sciences, 2018-07, Vol.120, p.73-88</ispartof><rights>2018 Elsevier B.V.</rights><rights>Copyright © 2018. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-c305c20f703b1950c95e2eff602ca64c3bc827c006cda8a7a414cb111870c3f73</citedby><cites>FETCH-LOGICAL-c356t-c305c20f703b1950c95e2eff602ca64c3bc827c006cda8a7a414cb111870c3f73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29719240$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Guney Eskiler, Gamze</creatorcontrib><creatorcontrib>Cecener, Gulsah</creatorcontrib><creatorcontrib>Dikmen, Gokhan</creatorcontrib><creatorcontrib>Egeli, Unal</creatorcontrib><creatorcontrib>Tunca, Berrin</creatorcontrib><title>Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer</title><title>European journal of pharmaceutical sciences</title><addtitle>Eur J Pharm Sci</addtitle><description>The objective of the present study was to investigate the effect of tamoxifen (Tam) loaded solid lipid nanoparticles (SLNs) on MCF7 Tam-resistant breast cancer cells (MCF7-TamR). Tam-SLNs were produced by the hot homogenization method. The characterization studies of Tam-SLNs demonstrated good physical stability with small particle size. The in vitro cytotoxicity results showed that Tam-SLNs enhanced the efficacy of Tam and reversed the acquired Tam resistance by inducing apoptosis, altering the expression levels of specific miRNA and the related apoptosis-associated target-genes in both MCF7 and MCF7-TamR cells without damaging the MCF10A control cells (p &lt; 0.05). In conclusion, we demonstrated a molecular mechanism of the induction of apoptosis by Tam-SLNs in MCF7 and MCF7-TamR cells, and thus, we demonstrated that Tam-SLNs were more effective than Tam. The present study suggests that the use SLNs may be a potential therapeutic strategy to overcome Tam-resistance in breast cancer for clinical use. Tam-SLNs could potentially overcome Tam-resistance by inducing apoptosis in breast cancer. [Display omitted]</description><subject>Apoptosis</subject><subject>Breast cancer</subject><subject>Drug resistance</subject><subject>Solid lipid nanoparticles</subject><subject>Tamoxifen</subject><issn>0928-0987</issn><issn>1879-0720</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kElLxEAQhRtRnHH0D3iQHL0kVneWTsSLDG4wILicm06lAh2y2Z0R_fd2mNGjULyi4NWj6mPsnEPEgWdXTUTN6CIBPI8g8QUHbMlzWYQgBRyyJRQiD6HI5YKdONcAQJZLOGYLUUheiASWbPM6tKYKWjN67XU_jNpOBlty18ELfZJ1ug2GOph0N3yZmvrAkjNu0j1SYPqgtKTdFOA821N2VOvW0dm-r9j7_d3b-jHcPD88rW83IcZpNnmFFAXUEuKSFylgkZKgus5AoM4SjEvMhUR_LVY611InPMGSc_8aYFzLeMUud7mjHT625CbVGYfUtrqnYeuUgDgRuUzFbBU7K9rBOUu1Gq3ptP1WHNRMUTVqpqhmigoSX-CXLvb527Kj6m_lF5s33OwM5L_8NGSVQ0MeQWUs4aSqwfyX_wNploNl</recordid><startdate>20180730</startdate><enddate>20180730</enddate><creator>Guney Eskiler, Gamze</creator><creator>Cecener, Gulsah</creator><creator>Dikmen, Gokhan</creator><creator>Egeli, Unal</creator><creator>Tunca, Berrin</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20180730</creationdate><title>Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer</title><author>Guney Eskiler, Gamze ; Cecener, Gulsah ; Dikmen, Gokhan ; Egeli, Unal ; Tunca, Berrin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-c305c20f703b1950c95e2eff602ca64c3bc827c006cda8a7a414cb111870c3f73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Apoptosis</topic><topic>Breast cancer</topic><topic>Drug resistance</topic><topic>Solid lipid nanoparticles</topic><topic>Tamoxifen</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Guney Eskiler, Gamze</creatorcontrib><creatorcontrib>Cecener, Gulsah</creatorcontrib><creatorcontrib>Dikmen, Gokhan</creatorcontrib><creatorcontrib>Egeli, Unal</creatorcontrib><creatorcontrib>Tunca, Berrin</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Guney Eskiler, Gamze</au><au>Cecener, Gulsah</au><au>Dikmen, Gokhan</au><au>Egeli, Unal</au><au>Tunca, Berrin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer</atitle><jtitle>European journal of pharmaceutical sciences</jtitle><addtitle>Eur J Pharm Sci</addtitle><date>2018-07-30</date><risdate>2018</risdate><volume>120</volume><spage>73</spage><epage>88</epage><pages>73-88</pages><issn>0928-0987</issn><eissn>1879-0720</eissn><abstract>The objective of the present study was to investigate the effect of tamoxifen (Tam) loaded solid lipid nanoparticles (SLNs) on MCF7 Tam-resistant breast cancer cells (MCF7-TamR). Tam-SLNs were produced by the hot homogenization method. The characterization studies of Tam-SLNs demonstrated good physical stability with small particle size. The in vitro cytotoxicity results showed that Tam-SLNs enhanced the efficacy of Tam and reversed the acquired Tam resistance by inducing apoptosis, altering the expression levels of specific miRNA and the related apoptosis-associated target-genes in both MCF7 and MCF7-TamR cells without damaging the MCF10A control cells (p &lt; 0.05). In conclusion, we demonstrated a molecular mechanism of the induction of apoptosis by Tam-SLNs in MCF7 and MCF7-TamR cells, and thus, we demonstrated that Tam-SLNs were more effective than Tam. The present study suggests that the use SLNs may be a potential therapeutic strategy to overcome Tam-resistance in breast cancer for clinical use. Tam-SLNs could potentially overcome Tam-resistance by inducing apoptosis in breast cancer. [Display omitted]</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>29719240</pmid><doi>10.1016/j.ejps.2018.04.040</doi><tpages>16</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0928-0987
ispartof European journal of pharmaceutical sciences, 2018-07, Vol.120, p.73-88
issn 0928-0987
1879-0720
language eng
recordid cdi_proquest_miscellaneous_2034287527
source Elsevier
subjects Apoptosis
Breast cancer
Drug resistance
Solid lipid nanoparticles
Tamoxifen
title Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T15%3A42%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Solid%20lipid%20nanoparticles:%20Reversal%20of%20tamoxifen%20resistance%20in%20breast%20cancer&rft.jtitle=European%20journal%20of%20pharmaceutical%20sciences&rft.au=Guney%20Eskiler,%20Gamze&rft.date=2018-07-30&rft.volume=120&rft.spage=73&rft.epage=88&rft.pages=73-88&rft.issn=0928-0987&rft.eissn=1879-0720&rft_id=info:doi/10.1016/j.ejps.2018.04.040&rft_dat=%3Cproquest_cross%3E2034287527%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-c305c20f703b1950c95e2eff602ca64c3bc827c006cda8a7a414cb111870c3f73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2034287527&rft_id=info:pmid/29719240&rfr_iscdi=true